Skip to main content
Premium Trial:

Request an Annual Quote

Aetna Covers Interpace Dx's Thyroid Cancer Test

NEW YORK (GenomeWeb) – Interpace Diagnostics said on Monday that Aetna has published a favorable coverage policy for the firm's ThyGenX genetic mutation panel for assessing fine needle aspiration samples from indeterminate thyroid nodules. 

Interpace, a subsidiary of PDI, said that Aetna considers the test medically necessary and started covering the test last month. PDI CEO Nancy Lurker added in a statement that Aetna is the first major commercial insurer to cover ThyGenX. The insurer covers 46 million lives and with the positive coverage decision, the number of covered lives for ThyGenX totals more than 100 million. 

ThyGenX is a next-generation sequencing-based panel for making surgical decisions about patients with thyroid nodules when standard cytopathology does not provide a clear diagnosis for thyroid cancer. It assists clinicians differentiate between benign and malignant indeterminate thyroid nodules by identifying more than 100 genetic alterations associated with papillary and follicular thyroid carcinomas. 

Interpace said that the 15 to 30 percent of the 525,000 thyroid fine needle aspiration samples performed each year that are indeterminate based on standard cytology are candidates for the test. ThyGenX was validated in a prospective, clinical study with more than 600 patients and has a specificity of 89 percent.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.